For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Axcella Health Inc.

USPTO Granted Patents = 25

% Expired Patents = 12.0

EPO Patents = 1

Trademarks = 4

Forward Citations = 168

Loading Chart...

Loading Chart...

41 inventors (with patents filed for the assignee):

Michael Hamill (21 out of 22 patents)

David Arthur Berry (11 out of 87 patents)

Raffi Afeyan (11 out of 11 patents)

4. Nathaniel Silver (9 out of 13 patents)

5. Geoffrey Von Maltzahn (8 out of 104 patents)

6. John Kramarczyk (7 out of 7 patents)

7. Brett Adam Boghigian (7 out of 15 patents)

8. William Comb (6 out of 6 patents)

9. Chung-Wei Lee (5 out of 5 patents)

10. Rajeev Chillakuru (5 out of 8 patents)

11. Sean Carroll (5 out of 39 patents)

12. Harry Luithardt (4 out of 4 patents)

13. Ying-Ja Chen (3 out of 3 patents)

14. Matthew Russell (3 out of 3 patents)

15. Caitlyn Harvey (2 out of 2 patents)

Core Competencies:

Amino Acid Compositions

Liver Diseases

Fat Infiltration

Muscle Wasting

Nutritive Polypeptides

Post-Acute Sequelae

Traumatic Brain Injury

Hemoglobinopathies

Gastrointestinal Malabsorption

Nutritive Proteins

Charged Nutritive Proteins

Formulations

25 patents: Sort by Forward Citations

1. 11833127 - Compositions and methods for the treatment of fat infiltration in muscle (2023-12-05),

2. 11737999 - Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19 (2023-08-29),

3. 11679089 - Methods of manufacturing amino acid compositions (2023-06-20),

4. 11617731 - Amino acid compositions and their use for the treatment of traumatic brain injury (2023-04-04),

5. 11602511 - Amino acid compositions and methods for the treatment of liver diseases (2023-03-14),

6. 11571404 - Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting (2023-02-07),

7. 11357824 - Nutritive polypeptides and formulations thereof, and methods of production and use thereof (2022-06-14),

8. 11298332 - Compositions for therapy and health containing amino acids with bitter taste (2022-04-12),

9. 11129804 - Amino acid compositions and methods for the treatment of liver diseases (2021-09-28),

10. 11058654 - Compositions and methods for the treatment of hemoglobinopathies and thalassemias (2021-07-13),

11. 10973793 - Compositions and methods for the treatment of fat infiltration in muscle (2021-04-13),

12. 10682325 - Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting (2020-06-16),

13. 10660870 - Compositions and methods for the treatment of liver diseases and disorders associated with one or both of hyperammonemia or muscle wasting (2020-05-26),

14. 10596136 - Compositions and methods for the treatment of fat infiltration in muscle (2020-03-24),

15. 10471034 - Amino acid compositions and methods for the treatment of liver diseases (2019-11-12),

Company Overview

Axcella Health Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative therapies to improve health and well-being through the modulation of metabolic pathways. The company specializes in the research and development of amino acid-based therapeutics aimed at addressing various health conditions, including liver disease and metabolic disorders. Axcella leverages its proprietary technology platform to create solutions that enhance metabolic health and support overall physiological function.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

25 Patents

#112 in Cambridge, MA

#804 in Massachusetts

#13,370 in US

#25,730 in the World

Cambridge, MA, United States of America

Axcella Health Inc.

Forward Citations = 168

41 inventors:

Michael Hamill (21 out of 22 patents)

David Arthur Berry (11 out of 87 patents)

Raffi Afeyan (11 out of 11 patents)

4. Nathaniel Silver (9 out of 13 patents)

5. Geoffrey Von Maltzahn (8 out of 104 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Axcella Health Inc.. Retrieved from https://idiyas.com/company/axcella-health

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…